ID   AURKB_HUMAN             Reviewed;         344 AA.
AC   Q96GD4; O14630; O60446; O95083; Q96DV5; Q9UQ46;
DT   17-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   17-JAN-2003, sequence version 2.
DT   02-NOV-2010, entry version 115.
DE   RecName: Full=Serine/threonine-protein kinase 12;
DE            EC=2.7.11.1;
DE   AltName: Full=Aurora kinase B;
DE   AltName: Full=Aurora- and IPL1-like midbody-associated protein 1;
DE            Short=AIM-1;
DE   AltName: Full=Aurora/IPL1-related kinase 2;
DE            Short=ARK-2;
DE            Short=Aurora-related kinase 2;
DE   AltName: Full=STK-1;
DE   AltName: Full=Serine/threonine-protein kinase aurora-B;
GN   Name=AURKB; Synonyms=AIK2, AIM1, ARK2, STK12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=98183439; PubMed=9514916; DOI=10.1006/bbrc.1998.8250;
RA   Shindo M., Nakano H., Kuroyanagi H., Shirasawa T., Mihara M.,
RA   Gilbert D.J., Jenkins N.A., Copeland N.G., Yagita H., Okumura K.;
RT   "cDNA cloning, expression, subcellular localization, and chromosomal
RT   assignment of mammalian aurora homologues, aurora-related kinase (ARK)
RT   1 and 2.";
RL   Biochem. Biophys. Res. Commun. 244:285-292(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   MEDLINE=99025855; PubMed=9809983;
RA   Tatsuka M., Katayama H., Ota T., Tanaka T., Odashima S., Suzuki F.,
RA   Terada Y.;
RT   "Multinuclearity and increased ploidy caused by overexpression of the
RT   aurora- and Ipl1-like midbody-associated protein mitotic kinase in
RT   human cancer cells.";
RL   Cancer Res. 58:4811-4816(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Liver, and Spleen;
RX   MEDLINE=99077743; PubMed=9858806;
RA   Kimura M., Matsuda Y., Yoshioka T., Sumi N., Okano Y.;
RT   "Identification and characterization of STK12/Aik2: a human gene
RT   related to aurora of Drosophila and yeast IPL1.";
RL   Cytogenet. Cell Genet. 82:147-152(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=21364697; PubMed=11471245;
RA   Prigent C., Gill R., Trower M., Sanseau P.;
RT   "In silico cloning of a new protein kinase, Aik2, related to
RT   Drosophila aurora using the new tool: EST Blast.";
RL   In Silico Biol. 1:123-128(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Zhang Q., Yu L., Bi A.;
RT   "Cloning of a novel human gene homologous to mouse STK-1.";
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT MET-298.
RC   TISSUE=Lung, Lymph, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   REVIEW.
RX   MEDLINE=21306577; PubMed=11413462; DOI=10.1038/35048096;
RA   Nigg E.A.;
RT   "Mitotic kinases as regulators of cell division and its checkpoints.";
RL   Nat. Rev. Mol. Cell Biol. 2:21-32(2001).
RN   [9]
RP   FUNCTION IN PHOSPHORYLATION OF HISTONE H3.
RX   PubMed=11856369; DOI=10.1046/j.1356-9597.2001.00498.x;
RA   Goto H., Yasui Y., Nigg E.A., Inagaki M.;
RT   "Aurora-B phosphorylates Histone H3 at serine28 with regard to the
RT   mitotic chromosome condensation.";
RL   Genes Cells 7:11-17(2002).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF HISTONE H3.
RX   PubMed=11784863; DOI=10.1128/MCB.22.3.874-885.2002;
RA   Crosio C., Fimia G.M., Loury R., Kimura M., Okano Y., Zhou H., Sen S.,
RA   Allis C.D., Sassone-Corsi P.;
RT   "Mitotic phosphorylation of histone H3: spatio-temporal regulation by
RT   mammalian Aurora kinases.";
RL   Mol. Cell. Biol. 22:874-885(2002).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH RACGAP1.
RX   PubMed=12689593; DOI=10.1016/S1534-5807(03)00089-3;
RA   Minoshima Y., Kawashima T., Hirose K., Tonozuka Y., Kawajiri A.,
RA   Bao Y.C., Deng X., Tatsuka M., Narumiya S., May W.S. Jr., Nosaka T.,
RA   Semba K., Inoue T., Satoh T., Inagaki M., Kitamura T.;
RT   "Phosphorylation by aurora B converts MgcRacGAP to a RhoGAP during
RT   cytokinesis.";
RL   Dev. Cell 4:549-560(2003).
RN   [12]
RP   INTERACTION WITH PSMA3.
RX   PubMed=14674694; DOI=10.1023/A:1027317014159;
RA   Shu F., Guo S., Dang Y., Qi M., Zhou G., Guo Z., Zhang Y., Wu C.,
RA   Zhao S., Yu L.;
RT   "Human Aurora-B binds to a proteasome alpha-subunit HC8 and undergoes
RT   degradation in a proteasome-dependent manner.";
RL   Mol. Cell. Biochem. 254:157-162(2003).
RN   [13]
RP   FUNCTION.
RX   PubMed=15020684; DOI=10.1242/jcs.01006;
RA   Johnson V.L., Scott M.I., Holt S.V., Hussein D., Taylor S.S.;
RT   "Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-
RT   F and Mad2, and chromosome congression.";
RL   J. Cell Sci. 117:1577-1589(2004).
RN   [14]
RP   INTERACTION WITH CDCA8.
RX   PubMed=15249581; DOI=10.1083/jcb.200404001;
RA   Gassmann R., Carvalho A., Henzing A.J., Ruchaud S., Hudson D.F.,
RA   Honda R., Nigg E.A., Gerloff D.L., Earnshaw W.C.;
RT   "Borealin: a novel chromosomal passenger required for stability of the
RT   bipolar mitotic spindle.";
RL   J. Cell Biol. 166:179-191(2004).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH CDCA1 AND NDC80.
RX   PubMed=14602875; DOI=10.1074/mcp.M300072-MCP200;
RA   Tien A.-C., Lin M.-H., Su L.-J., Hong Y.-R., Cheng T.-S., Lee Y.-C.G.,
RA   Lin W.-J., Still I.H., Huang C.-Y.F.;
RT   "Identification of the substrates and interaction proteins of aurora
RT   kinases from a protein-protein interaction model.";
RL   Mol. Cell. Proteomics 3:93-104(2004).
RN   [16]
RP   INTERACTION WITH TACC1.
RX   PubMed=15064709; DOI=10.1038/sj.onc.1207593;
RA   Delaval B., Ferrand A., Conte N., Larroque C., Hernandez-Verdun D.,
RA   Prigent C., Birnbaum D.;
RT   "Aurora B -TACC1 protein complex in cytokinesis.";
RL   Oncogene 23:4516-4522(2004).
RN   [17]
RP   SUBCELLULAR LOCATION, INTERACTION WITH SEPT1, AND MUTAGENESIS OF
RP   LYS-106.
RX   PubMed=16179162; DOI=10.1016/j.bbrc.2005.06.212;
RA   Qi M., Yu W., Liu S., Jia H., Tang L., Shen M., Yan X., Saiyin H.,
RA   Lang Q., Wan B., Zhao S., Yu L.;
RT   "Septin1, a new interaction partner for human serine/threonine kinase
RT   aurora-B.";
RL   Biochem. Biophys. Res. Commun. 336:994-1000(2005).
RN   [18]
RP   INTERACTION WITH EVI5.
RX   PubMed=16764853; DOI=10.1016/j.yexcr.2006.03.032;
RA   Faitar S.L., Sossey-Alaoui K., Ranalli T.A., Cowell J.K.;
RT   "EVI5 protein associates with the INCENP-aurora B kinase-survivin
RT   chromosomal passenger complex and is involved in the completion of
RT   cytokinesis.";
RL   Exp. Cell Res. 312:2325-2335(2006).
RN   [19]
RP   FUNCTION.
RX   PubMed=17617734;
RA   Pouwels J., Kukkonen A.M., Lan W., Daum J.R., Gorbsky G.J.,
RA   Stukenberg T., Kallio M.J.;
RT   "Shugoshin 1 plays a central role in kinetochore assembly and is
RT   required for kinetochore targeting of Plk1.";
RL   Cell Cycle 6:1579-1585(2007).
RN   [20]
RP   UBIQUITINATION.
RX   PubMed=17543862; DOI=10.1016/j.devcel.2007.03.019;
RA   Sumara I., Quadroni M., Frei C., Olma M.H., Sumara G., Ricci R.,
RA   Peter M.;
RT   "A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes,
RT   regulating mitotic progression and completion of cytokinesis in human
RT   cells.";
RL   Dev. Cell 12:887-900(2007).
RN   [21]
RP   INTERACTION WITH BIRC5.
RX   PubMed=18591255; DOI=10.1128/MCB.02039-07;
RA   Xia F., Canovas P.M., Guadagno T.M., Altieri D.C.;
RT   "A survivin-ran complex regulates spindle formation in tumor cells.";
RL   Mol. Cell. Biol. 28:5299-5311(2008).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; TYR-12 AND THR-232,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Cervix adenocarcinoma;
RX   PubMed=16565220; DOI=10.1073/pnas.0507066103;
RA   Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
RT   "Phosphoproteome analysis of the human mitotic spindle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; THR-16; THR-35;
RP   SER-45; SER-61; SER-62 AND THR-64, ACETYLATION [LARGE SCALE ANALYSIS]
RP   AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=19007248; DOI=10.1021/ac801708p;
RA   Wang B., Malik R., Nigg E.A., Korner R.;
RT   "Evaluation of the low-specificity protease elastase for large-scale
RT   phosphoproteome analysis.";
RL   Anal. Chem. 80:9526-9533(2008).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-232, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; THR-35; SER-45;
RP   SER-61; THR-64; TYR-92; SER-227; THR-232; THR-236 AND SER-313, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-35, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [27]
RP   UBIQUITINATION.
RX   PubMed=19995937; DOI=10.1083/jcb.200906117;
RA   Maerki S., Olma M.H., Staubli T., Steigemann P., Gerlich D.W.,
RA   Quadroni M., Sumara I., Peter M.;
RT   "The Cul3-KLHL21 E3 ubiquitin ligase targets aurora B to midzone
RT   microtubules in anaphase and is required for cytokinesis.";
RL   J. Cell Biol. 187:791-800(2009).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-61, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [29]
RP   INTERACTION WITH INCENP.
RX   PubMed=20562864; DOI=10.1038/ncb2075;
RA   Nozawa R.S., Nagao K., Masuda H.T., Iwasaki O., Hirota T., Nozaki N.,
RA   Kimura H., Obuse C.;
RT   "Human POGZ modulates dissociation of HP1alpha from mitotic chromosome
RT   arms through Aurora B activation.";
RL   Nat. Cell Biol. 12:719-727(2010).
RN   [30]
RP   VARIANT MET-298.
RX   PubMed=16762494; DOI=10.1016/j.canlet.2006.05.002;
RA   Tchatchou S., Wirtenberger M., Hemminki K., Sutter C., Meindl A.,
RA   Wappenschmidt B., Kiechle M., Bugert P., Schmutzler R.K.,
RA   Bartram C.R., Burwinkel B.;
RT   "Aurora kinases A and B and familial breast cancer risk.";
RL   Cancer Lett. 247:266-272(2007).
RN   [31]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-52 AND MET-179.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May be directly involved in regulating the cleavage of
CC       polar spindle microtubules and is a key regulator for the onset of
CC       cytokinesis during mitosis. Component of the chromosomal passenger
CC       complex (CPC), a complex that acts as a key regulator of mitosis.
CC       The CPC complex has essential functions at the centromere in
CC       ensuring correct chromosome alignment and segregation and is
CC       required for chromatin-induced microtubule stabilization and
CC       spindle assembly. Phosphorylates 'Ser-10' and 'Ser-28' of histone
CC       H3 during mitosis. Required for kinetochore localization of BUB1
CC       and SGOL1. Interacts with INCENP.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- SUBUNIT: Interacts with TACC1. Associates with RACGAP1 during M
CC       phase. Component of the CPC at least composed of BIRC5/survivin
CC       CDCA8/borealin, INCENP and AURKB/Aurora-B. Interacts with CDCA1
CC       and NDC80. Interacts with EVI5. Interacts with SEPT1. Interacts
CC       with PSMA3.
CC   -!- INTERACTION:
CC       O15392:BIRC5; NbExp=6; IntAct=EBI-624291, EBI-518823;
CC       P06493:CDC2; NbExp=1; IntAct=EBI-624291, EBI-444308;
CC       Q9NQS7:INCENP; NbExp=1; IntAct=EBI-624291, EBI-307907;
CC       P62136:PPP1CA; NbExp=1; IntAct=EBI-624291, EBI-357253;
CC       Q8WYJ6:SEPT1; NbExp=3; IntAct=EBI-624291, EBI-693002;
CC       O75410:TACC1; NbExp=3; IntAct=EBI-624291, EBI-624237;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Chromosome, centromere.
CC       Cytoplasm, cytoskeleton, spindle. Note=Localizes on chromosome
CC       arms and inner centromeres from prophase through metaphase and
CC       then transferring to the spindle midzone and midbody from anaphase
CC       through cytokinesis. Colocalized with gamma tubulin in the mid-
CC       body.
CC   -!- TISSUE SPECIFICITY: High level expression seen in the thymus. It
CC       is also expressed in the spleen, lung, testis, colon, placenta and
CC       fetal liver. Expressed during S and G2/M phase and expression is
CC       up-regulated in cancer cells during M phase.
CC   -!- PTM: Ubiquitinated by different BCR (BTB-CUL3-RBX1) E3 ubiquitin
CC       ligase complexes. Ubiquitinated by the BCR(KLHL9-KLHL13) E3
CC       ubiquitin ligase complex, ubiquitination leads to removal from
CC       mitotic chromosomes and is required for cytokinesis. During
CC       anaphase, the BCR(KLHL21) E3 ubiquitin ligase complex recruits the
CC       CPC complex from chromosomes to the spindle midzone and mediates
CC       the ubiquitination of AURKB. Ubiquitination of AURKB by
CC       BCR(KLHL21) E3 ubiquitin ligase complex may not lead to its
CC       degradation by the proteasome.
CC   -!- DISEASE: Note=Disruptive regulation of expression is a possibile
CC       mechanism of the perturbation of chromosomal integrity in cancer
CC       cells through its dominant-negative effect on cytokinesis.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. Aurora subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH13300.2; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF008552; AAC12709.1; -; mRNA.
DR   EMBL; AB011450; BAA32136.1; -; mRNA.
DR   EMBL; AB011446; BAA82709.1; -; mRNA.
DR   EMBL; AF004022; AAB65786.1; -; mRNA.
DR   EMBL; AF015254; AAC98891.1; -; mRNA.
DR   EMBL; BT019534; AAV38341.1; -; mRNA.
DR   EMBL; BC000442; AAH00442.3; -; mRNA.
DR   EMBL; BC009751; AAH09751.1; -; mRNA.
DR   EMBL; BC013300; AAH13300.2; ALT_INIT; mRNA.
DR   EMBL; BC080581; AAH80581.1; -; mRNA.
DR   IPI; IPI00176642; -.
DR   RefSeq; NP_004208.2; -.
DR   UniGene; Hs.442658; -.
DR   ProteinModelPortal; Q96GD4; -.
DR   SMR; Q96GD4; 70-337.
DR   DIP; DIP-34530N; -.
DR   IntAct; Q96GD4; 42.
DR   MINT; MINT-1413997; -.
DR   STRING; Q96GD4; -.
DR   PhosphoSite; Q96GD4; -.
DR   PRIDE; Q96GD4; -.
DR   Ensembl; ENST00000316199; ENSP00000313950; ENSG00000178999.
DR   GeneID; 9212; -.
DR   KEGG; hsa:9212; -.
DR   UCSC; uc002gkm.1; human.
DR   CTD; 9212; -.
DR   GeneCards; GC17M008108; -.
DR   H-InvDB; HIX0019005; -.
DR   HGNC; HGNC:11390; AURKB.
DR   HPA; CAB005862; -.
DR   MIM; 604970; gene.
DR   PharmGKB; PA36199; -.
DR   eggNOG; prNOG08834; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108519; -.
DR   InParanoid; Q96GD4; -.
DR   OrthoDB; EOG9ZW7WT; -.
DR   PhylomeDB; Q96GD4; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; aurora_a_pathway; Aurora A signaling.
DR   Pathway_Interaction_DB; aurora_b_pathway; Aurora B signaling.
DR   Pathway_Interaction_DB; aurora_c_pathway; Aurora C signaling.
DR   Pathway_Interaction_DB; foxm1pathway; FOXM1 transcription factor network.
DR   Pathway_Interaction_DB; aurora_kinase_pathway; Signaling by Aurora kinases.
DR   Reactome; REACT_152; Cell Cycle, Mitotic.
DR   Reactome; REACT_383; DNA Replication.
DR   NextBio; 34535; -.
DR   ArrayExpress; Q96GD4; -.
DR   Bgee; Q96GD4; -.
DR   CleanEx; HS_AIM1; -.
DR   CleanEx; HS_AURKB; -.
DR   Genevestigator; Q96GD4; -.
DR   GermOnline; ENSG00000178999; Homo sapiens.
DR   GO; GO:0032133; C:chromosome passenger complex; IPI:UniProtKB.
DR   GO; GO:0000780; C:condensed nuclear chromosome, centromeric r...; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0007067; P:mitosis; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0034501; P:protein localization to kinetochore; IMP:UniProtKB.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR020663; Spindle_assmbl_checkpoint_kin.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF49; Spindle_assmbl_checkpoint_kin; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cell cycle; Cell division; Centromere;
KW   Chromosome; Complete proteome; Cytoplasm; Cytoskeleton; Kinase;
KW   Magnesium; Metal-binding; Mitosis; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase; Ubl conjugation.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    344       Serine/threonine-protein kinase 12.
FT                                /FTId=PRO_0000085656.
FT   DOMAIN       77    327       Protein kinase.
FT   NP_BIND      83     91       ATP (By similarity).
FT   ACT_SITE    200    200       Proton acceptor (By similarity).
FT   BINDING     106    106       ATP (By similarity).
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES       7      7       Phosphoserine.
FT   MOD_RES      12     12       Phosphotyrosine.
FT   MOD_RES      16     16       Phosphothreonine.
FT   MOD_RES      35     35       Phosphothreonine.
FT   MOD_RES      45     45       Phosphoserine.
FT   MOD_RES      61     61       Phosphoserine.
FT   MOD_RES      62     62       Phosphoserine.
FT   MOD_RES      64     64       Phosphothreonine.
FT   MOD_RES      92     92       Phosphotyrosine.
FT   MOD_RES     227    227       Phosphoserine.
FT   MOD_RES     232    232       Phosphothreonine.
FT   MOD_RES     236    236       Phosphothreonine.
FT   MOD_RES     313    313       Phosphoserine.
FT   VARIANT      52     52       A -> V.
FT                                /FTId=VAR_040383.
FT   VARIANT     100    100       H -> Q (in dbSNP:rs3027254).
FT                                /FTId=VAR_027970.
FT   VARIANT     179    179       T -> M.
FT                                /FTId=VAR_040384.
FT   VARIANT     298    298       T -> M (in dbSNP:rs1059476).
FT                                /FTId=VAR_027971.
FT   MUTAGEN     106    106       K->R: Loss of kinase activity.
FT   CONFLICT     14     15       RQ -> DK (in Ref. 5; AAC98891).
FT   CONFLICT     70     70       R -> RR (in Ref. 7; AAH13300).
FT   CONFLICT    161    161       E -> M (in Ref. 4 and 5).
FT   CONFLICT    167    169       QKS -> HKT (in Ref. 4; AAB65786).
FT   CONFLICT    179    179       T -> TVRR (in Ref. 4; AAB65786).
FT   CONFLICT    180    180       I -> VRAV (in Ref. 5).
FT   CONFLICT    226    226       P -> T (in Ref. 3; BAA82709).
FT   CONFLICT    249    250       MH -> ID (in Ref. 3; BAA82709).
FT   CONFLICT    271    271       Missing (in Ref. 3; BAA82709).
SQ   SEQUENCE   344 AA;  39280 MW;  8325E3EF5A1FB170 CRC64;
     MAQKENSYPW PYGRQTAPSG LSTLPQRVLR KEPVTPSALV LMSRSNVQPT AAPGQKVMEN
     SSGTPDILTR HFTIDDFEIG RPLGKGKFGN VYLAREKKSH FIVALKVLFK SQIEKEGVEH
     QLRREIEIQA HLHHPNILRL YNYFYDRRRI YLILEYAPRG ELYKELQKSC TFDEQRTATI
     MEELADALMY CHGKKVIHRD IKPENLLLGL KGELKIADFG WSVHAPSLRR KTMCGTLDYL
     PPEMIEGRMH NEKVDLWCIG VLCYELLVGN PPFESASHNE TYRRIVKVDL KFPASVPTGA
     QDLISKLLRH NPSERLPLAQ VSAHPWVRAN SRRVLPPSAL QSVA
//
